학술논문

FKB327, an adalimumab biosimilar, versus the reference product: Results of a randomized, Phase III, double-blind study, and its open-label extension
Document Type
Article
Source
In: Arthritis Research and Therapy. (Arthritis Research and Therapy, 12 December 2019, 21(1))
Subject
Language
English
ISSN
14786362
14786354